Amryt Predicts $1bn Revenues After Chiasma Acquisition
Buying Mycapssa, Only Approved Oral Acromegaly Therapy
The Irish drugmaker will have three approved commercial products for rare diseases – Mycapssa, Lojuxta and Myalept – with a potential fourth therapy on the way now Filsuvez has been filed for butterfly skin.
